The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
3M Drug Delivery Systems Division St. Paul, MN www.3m.com/dds (800) 643-8086 DRUG TYPE: Biopharmaceuticals DRUG LIFE CYCLE STAGES: Formulated Drug Production – dosage form development and dosage form production Manufacturing locations: Argentina, United Kingdom, and United States Contact: Anne Roush aroush@mmm.com DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, creams & ointments, generics, hollow and solid microneedle systems, injectables, integrated dose-by-dose counters and inhalation drug delivery components, metered dose inhalers, packaging films, solid dose, topicals, and transdermal drug delivery systems and components. "3M Drug Delivery Systems is proud to be recognized globally for our expertise in drug delivery systems development and manufacturing, integrated with quality assurance and regulatory support. Our success is driven by our dedication to taking care of customers, and our commitment to high standards for safety and compliance. We combine 3M state-of-the-art technology with our expertise in formulation and a full range of capabilities, to offer pharmaceutical companies an outstanding value in partnership and contract manufacturing services." — James Ingebrand, president and general manager ACIC Brantford, Ontario, Canada www.acic.com (519) 751-3668 DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Drug Substance Production – drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, cytotoxic & high potency compounds, generics, injectables, lyophilized products, ophthalmics, parenterals (large volume), parenterals (small volume), powders (non-sterile), powders (sterile), soft gels, solid dose, sterile, and sustained release. "The ACIC group is a supplier of APIs, finished dosage forms, and services to the pharmaceutical industry. Since 1974, we have helped move projects from 'Molecule to Market.' In addition to our own capabilities, we are able to leverage a network of research, API, and FDF manufacturing facilities. Our regulatory expertise covers DMFs, ANDAs, and NDAs. Whether you require a few grams or tons, a solid or semi-solid, or an injectable product, we have the fully integrated means to assist you." — Luciano Calenti, president 34 The CMO Leadership Awards 2012 Manufacturing locations: Contact for details Contact: Chris Rayfield Crayfield@acic.com DRUG LIFE CYCLE STAGES: Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, creams & ointments, cytotoxic & high-potency compounds, generics, injectables, liquids, non-sterile, OTC, parenterals (large volume), parenterals (small volume), solid dose, solutions & suspensions, sterile, sustained release, and topicals. "It's an honour to receive the CMO Leadership award and be recognized as a leader in the fields of quality, reliability, and innovation, as we believe these areas play a fundamental role in the overarching offer of an integrated CMO. While the last 18 months have seen us double our workforce and expand our manufacturing presence in Europe, we are committed to continually expanding and enhancing our service to ensure we remain at the forefront of our field." — Dr. Robert Hardy, CEO DRUG TYPE: Pharmaceuticals and Biopharmaceuticals SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, cytotoxic & high-potency compounds, generics, injectables, lyophilized products, non-sterile, parenterals (small volume), peptides, powders (non-sterile), proteins, semisolids, solid dose, solutions & suspensions, sterile, and sustained release. "Our world-class scientific and technical teams are dedicated to delivering consistent, quality results with each project. Supported by integrated operations and project management, we collaborate directly with our clients to meet all analytical testing needs accurately and quickly. AAIPharma's exemplary audit and compliance track record reflect our commitment to developing the highest-quality formulations, dosage forms, and analytical results. Our clients recognize our desire to provide first-rate service across every service offering in our portfolio." — Patrick Walsh, chief executive officer Aesica Pharmaceuticals Newcastle upon Tyne, United Kingdom www.aesica-pharma.com 44 191 218 1960 Manufacturing locations: Germany, Italy, and United Kingdom Contact: Alison Doering alison.doering@aesica-pharma.com AAIPharma Services Corp. Wilmington, NC www.aaipharma.com (800) 575-4224 Manufacturing locations: Charleston, SC, and Wilmington, NC Contact: Timothy R. Compton Timothy.Compton@aaipharma.com DRUG LIFE CYCLE STAGES